Articles tagged with: Immune System
Headline, News »
A high lymphocyte count at diagnosis may predict longer survival time for myelodysplastic syndromes (MDS) patients, according to a recent study published in the American Journal of Hematology.
Lymphocytes are a type of white blood cell that defend the body against infections and play a vital role in the body’s immune response. Lymphocyte count is a frequently used prognostic indicator in lymphoid cancers.
Previous research has shown that immune system may be linked to the development of MDS (see related Beacon article).
Currently, prognoses for MDS are determined using…
News »
Dr. Pearlie Epling-Burnette, from the H. Lee Moffitt Cancer Center & Research Institute, presented new research highlighting immune system disorders at the 10th Annual International Symposium for Myelodysplastic Syndromes (MDS) in Patras, Greece. Auto-immune diseases seem to affect some MDS patients, even though it is only a small percentage of the overall MDS patient population.
Her presentation on May 7, called “Controlling the ‘Fate’ of T-Cells in MDS,” focused on natural killer T-cells, white blood cells that are the immune system’s first non-specific defense against foreign pathogens and defective cells.…